Protein interaction and pathway analyses indicated that RBM15 participates in multiple biological processes, including cell cycle regulation, sister chromatid cohesion, serine/threonine phosphorylation, and T-cell receptor signaling, suggesting its role as a prognostic biomarker and potential immunotherapy target in PAAD. The gene discussed is RBM15; the disease is pancreatic adenocarcinoma.